Commercial Use
Commercial use of levomefolic acid in pharmaceutical products began in Europe in the early part of this decade and have now appeared in the U.S. This approach to folate supplementation has potential to impact prenatal care, homocysteine management, and the treatment of depression, dementia and cardiovascular concerns.
- Prenatal care: low folate status has been linked to neural tube defects, recurrent pregnancy loss, low birth weight and a variety of age-related high risk complications of pregnancy.
- Homocysteine management: elevated homocysteine is frequently linked to the presence of the MTHFR polymorphism.
- Depression: folate status has been linked to the performance of SSRI drugs. Many patients have required folate supplementation in order to adequately respond to standard treatment protocol.
- Dementia: folate status has been linked to the efficacy of neural transmitters and cognitive performance. Only active, levomefolic acid can cross the blood brain barrier.
- Diabetic neuropathy: folate status has been shown to have a substantial impact upon wound care.
Read more about this topic: Levomefolic Acid
Famous quotes containing the word commercial:
“The commercial class has always mistrusted verbal brilliancy and wit, deeming such qualities, perhaps with some justice, frivolous and unprofitable.”
—Dorothy Nevill (1826–1913)
“It is only by not paying one’s bills that one can hope to live in the memory of the commercial classes.”
—Oscar Wilde (1854–1900)